Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-29T14:18:13.588Z Has data issue: false hasContentIssue false
  • English
  • Français

Acute Quadriplegic Myopathy Unrelated to Steroids or Paralyzing Agents: Quantitative EMG Studies

Published online by Cambridge University Press:  02 December 2014

Ahmet Höke ,
Douglas W. Zochodne  and
N. B. Rewcastle
Ahmet Höke
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
Douglas W. Zochodne
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
N. B. Rewcastle
Affiliation:
Department and Pathology, University of Calgary, Calgary, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Quadriplegic myopathy (QM) and its variants generally are described in critically ill patients who are exposed to steroids and nondepolarizing muscle blocking agents (NDMBAs).

Methods:

A patient with sepsis who was not exposed to steroids or an NDMBA infusion developed QM and was studied using serial quantitative electromyography.

Results:

Clinical and electrophysiological studies identified evidence of a severe myopathy and muscle biopsy showed necrosis, calcifications and selective loss of myosin filaments in non-necrotic fibers. Her clinical recovery paralleled rises in motor unit action potential (MUAP) amplitudes studied by serial automatic decomposition electromyography (ADEMG).

Conclusion:

QM can develop with sepsis and without significant exposure to steroids and NDMBAs. ADEMG can be a useful tool in electrophysiological evaluation of critically ill patients with weakness.

Résumé

RÉSUMÉIntroduction:

La myopathie quadriplégique (MQ) et ses variantes sont généralement décrites chez des patients dont l’état est critique et qui sont exposés à des stéroïdes et à des bloquants musculaires non dépolarisants (BMNDs).

Méthodes:

Une patiente atteinte de septicémie, qui n’avait pas été exposée à des stéroïdes ou à une perfusion de BMND, a développé une MQ. Nous avons procédé chez cette patiente à une étude électromyographique quantitative sériée.

Réltats:

Les études cliniques et électrophysiologiques ont montré des manifestations de myopathie sévère, et à la biopsie musculaire, on a observé une nécrose, des calcifications et une perte sélective des filaments de myosine dans les fibres qui n’étaient pas nécrotiques. Sa récupération Clinique a été parallèle à l’augmentation de l’amplitude des potentiels d’action des unités motrices notée à l’électromyographie de décomposition automatique sériée (ÉMGDA).

Conclusions:

Une MQ peut survenir chez les patients septiques, sans exposition significative à des stéroïdes et à des BMNDs. L’ÉMGDA peut être un outil précieux dans l’évaluation électrophysiologique de patients en état critique qui présentent de la faiblesse musculaire.

Type
Case Report
Information
Canadian Journal of Neurological Sciences , Volume 26 , Issue 4 , November 1999 , pp. 325 - 329
Copyright
Copyright © The Canadian Journal of Neurological 1999

References

References:

1. MacFarlane, IA, Rosenthal, FD. Severe myopathy after statusasthmaticus. Lancet 1977;2:615.Google Scholar
2. Danon, MJ, Carpenter, S. Myopathy with thick filament (myosin)loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131–9.Google Scholar
3. McGill, KC, Dorfman, LJ. Automatic decomposition electromyogra-phy (ADEMG): validation and normative data in brachial biceps. Electroencephalogr Clin Neurophysiol 1985;61:453–61.Google Scholar
4. Van Marle, W, Woods, KL. Acute hydrocortisone myopathy. Br MedJ 1980;281:271–2.Google Scholar
5. Helliwell, TR, Coakley, JH, Wagenmakers, AJ, Griffiths, RD, Campbell, IT, Green, CJ, et al. Necrotizing myopathy in critically ill patients. J Pathol 1991;164:307–14.Google Scholar
6. Ramsay, DA, Zochodne, DW, Robertson, DM, Nag, S, Ludwin, SK. Asyndrome of acute severe muscle necrosis in intensive care unitpatients. J Neuropathol Exp Neurol 1993;52:387–98.CrossRefGoogle Scholar
7. Zochodne, DW, Ramsay, DA, Saly, V, Shelley, S, Moffatt, S. Acutenecrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994;17:285–92.Google Scholar
8. Lacomis, D, Giuliani, MJ, Van Cott, A, Kramer, DJ. Acute myopathyof intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40:645–54.Google Scholar
9. Matsubara, S, Okada, T, Yoshida, M. Mitochondrial changes in acutemyopathy after treatment of respiratory failure with mechanical ventilation (acute relaxant-steroid myopathy). Acta Neuropathol(Berl) 1994;88:475–8.Google Scholar
10. Fischer, JR, Baer, RK. Acute myopathy associated with combineduse of corticosteroids and neuromuscular blocking agents. Ann Pharmacother 1996;30:1437–45.CrossRefGoogle Scholar
11. al-Lozi, MT, Pestronk, A, Yee, WC, Flaris, N, Cooper, J. Rapidlyevolving myopathy with myosin-deficient muscle fibers. Ann Neurol 1994;35:273–9.Google Scholar
12. Hanson, P, Dive, A, Brucher, JM, Bisteau, M, Dangoisse, M, Deltombe, T. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997;20:1371–80.Google Scholar
13. Showalter, CJ, Engel, AG. Acute quadriplegic myopathy: analysis ofmyosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316–22.Google Scholar
14. Barohn, RJ, Jackson, CE, Rogers, SJ, Ridings, LW, McVey, AL. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994;17:647–54.Google Scholar
15. Rich, MM, Teener, JW, Raps, EC, Schotland, DL, Bird, SJ. Muscle iselectrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731–6.CrossRefGoogle ScholarPubMed
16. Rich, MM, Bird, SJ, Raps, EC, McCluskey, LF, Teener, JW. Direct muscle stimulation in acute quadriplegic myopathy. MuscleNerve 1997;20:665–73.Google Scholar
17. Hirano, M, Ott, BR, Raps, EC, Minetti, C, Lennihan, L, et al. Acutequadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992;42:2082–7.Google Scholar
18. Massa, R, Carpenter, S, Holland, P, Karpati, G. Loss and renewal ofthick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992;15:1290–8.Google Scholar
19. The Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmaceutical Association, 1995.Google Scholar
20. Minetti, C, Hirano, M, Morreale, G, Pedemonte, M, Cordone, G, et al. Ubiquitin expression in acute steroid myopathy with loss of myosin thick filaments. Muscle Nerve 1996;19:94–6.Google Scholar
21. Bolton, CF. Neuromuscular complications of sepsis. Intensive Care Med 1993;19:S58–63.CrossRefGoogle ScholarPubMed
22. Bolton, CF. Sepsis and the systemic inflammatory responsesyndrome: neuromuscular manifestations. Crit Care Med 1996;24:1408–16.Google Scholar
23. Zochodne, DW, Bolton, CF, Wells, GA, Gilbert, JJ, Hahn, AF, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110:819–41.CrossRefGoogle ScholarPubMed
24. Zochodne, DW, Bolton, CF. Neuromuscular disorders in criticalillness. Baillieres Clin Neurol 1996;5:645–71.Google Scholar
25. Deconinck, N, Van Parijs, V, Beckers-Bleukx, G, Van den Bergh, P. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscular Disorders 1998;8:186–92.Google Scholar
26. Bolton, CF, Ramsay, DA, Rutledge, F. Acute quadriplegic myopathy(AQM), sepsis and systemic inflammatory response syndrome(SIRS). Neurology 1998;50:242–3.Google Scholar